No Data
Institutional Investors Have a Lot Riding on Teva Pharmaceutical Industries Limited (NYSE:TEVA) With 68% Ownership
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Express News | 'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
Pre-market drop of over 4%! Novo-Nordisk A/S's "weight loss miracle drug" enters price negotiations with USA healthcare.
The diabetes drug Ozempic and the weight loss drug Wegovy, among 15 other medications from Novo-Nordisk A/S, have been included in the USA government’s plan for Medicare price negotiations scheduled for 2027. After this announcement, Novo-Nordisk A/S's stock price was surpassed by LVMH, making it the second largest publicly traded company in Europe.
Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $30
Mangkawat : red day but its still stable
Jaguar8 OP Mangkawat : Nothing big news for me on this one unless it comes with a monetary award
Mangkawat Jaguar8 OP : how about $BioLine Rx (BLRX.US)$ bioline rx. any news ? drop and drop.
Jaguar8 OP Mangkawat : It made an offering days ago
Mangkawat Jaguar8 OP : but price look like on risk to be delist. still below $1 .
View more comments...